BenefitsPRO: Employee Benefits News, Trends & Sales Tips

New weight loss drugs, in various stages of development, could rival Ozempic

By Alan Goforth

Employers, faced with high costs in treating obesity-related chronic conditions, may want to consider the importance of providing access to the emerging weight loss medications, particularly with more options soon available.

Read Story

News

DOJ, states end fight over $7.8B UnitedHealth-Change Healthcare deal

News

ACA's Employer Mandate: IRS announces higher penalties for noncompliance

Recommended Just For You

Consumer Driven Health Care Stories

March 22, 2023

Florida: A 6-week abortion ban is introduced, as a 15-week ban heads to Supreme Court

As the legality of a 15-week ban on abortions is being debated in court, the state's legislature is considering a bill which would allow abortions past six weeks only when the mother's life was in danger, or in cases of rape or incest.

Read

March 22, 2023

New Medicare Drug Negotiation Program: Initial guidance from CMS

Because of the Inflation Reduction Act, Medicare will have the ability to negotiate lower prescription drug prices with manufacturers - and will release the negotiated fair prices for the first 10 drugs September 1.

Read

March 21, 2023

Senators are cracking down on telehealth companies sharing sensitive health data

In the wake of the FTC's recent $1.5 million settlement with GoodRx for disclosing health data with Facebook, lawmakers have introduced legislation and have sent letters to other telehealth providers.

Read

March 21, 2023

Wyoming becomes the first state to ban abortion pills

The new law, which makes it illegal to "prescribe, dispense, distribute, sell or use any drug" for performing an abortion, will take effect July 1.

Read

March 20, 2023

CMS releases guidance on Medicare drug rebate program, beginning April 1

The federal agency has lowered prices for 27 prescription drugs, including Minocin and Humira, with the cost difference being billed to drug makers.

Read

March 20, 2023

Access to abortion pill in the balance, awaiting Texas federal judge's decision

Last week, the judge heard arguments in a case that will decide the safety of mifepristone, one of the drugs in the two-pill regimen that has been used by 5.6 million women since 2000, according to the FDA.

Read

March 17, 2023

Employers call on Congress to focus on 4 key health policy priorities

Lawmakers should take "bold steps" to strengthen employer plans, reduce costs, promote telehealth and combat the mental health crisis, wrote the American Benefits Council in a letter.

Read

‹ ‹ PREV 150 151 152 ... 727 › NEXT ›

Consumer Driven Health Care

Top Consumer Driven Health Care Stories

New weight loss drugs, in various stages of development, could rival Ozempic

DOJ, states end fight over $7.8B UnitedHealth-Change Healthcare deal

ACA's Employer Mandate: IRS announces higher penalties for noncompliance

Recommended Just For You

Consumer Driven Health Care Stories

Florida: A 6-week abortion ban is introduced, as a 15-week ban heads to Supreme Court

New Medicare Drug Negotiation Program: Initial guidance from CMS

Senators are cracking down on telehealth companies sharing sensitive health data

Wyoming becomes the first state to ban abortion pills

CMS releases guidance on Medicare drug rebate program, beginning April 1

Access to abortion pill in the balance, awaiting Texas federal judge's decision

Employers call on Congress to focus on 4 key health policy priorities